DOD Ovarian Cancer Research Program FY20 funding opportunity

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The FY20 Defense Appropriations Act is anticipated to provide funding to the Department of Defense Ovarian Cancer Research Program to support patient-centered research to prevent, detect, treat, and cure ovarian cancer.

The FY 2020 Defense Appropriations Bill has not been signed into law—and although FY20 funds have not been appropriated for the Department of Defense Ovarian Cancer Research Program, the OCRP has published information to allow investigators time to plan and develop ideas for submission to the anticipated FY20 funding opportunities.

FY20 OCRP program announcements and general application instructions for the following award mechanism is posted on the Grants.gov website.

Table of Contents

YOU MAY BE INTERESTED IN

An updated version of President Trump’s budget request published on May 2 comes as a disappointment for those who hoped that the White House would rethink the draconian cuts contained in an earlier, confidential version of the document that ended up being leaked to the press. 
“We stand at the edge of discovery, and on the brink of losing it,” said Patricia M. LoRusso, the 2024-2025 president of the American Association for Cancer Research. “I believe this is the most scientifically promising moment in the history of cancer research.” 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login